Events & Presentations
EASL International Liver Congress 2020
Aug 27 - Aug 29, 2020
Maralixibat presentation and posters featured during the meeting include:
LB008: Serum bile acid control in long-term maralixibat-treated patients is associated with native liver survival in children with progressive familial intrahepatic cholestasis due to bile salt export pump deficiency.
Poster FRI-131: Psychometric evaluation of the adult itch reported outcome tool, a worst-itch numeric rating scale in adults with cholestatic liver disease.
Poster FRI-296: Differential expression of bile acid subspecies with maralixibat treatment in pruritus responders.
LB008: Serum bile acid control in long-term maralixibat-treated patients is associated with native liver survival in children with progressive familial intrahepatic cholestasis due to bile salt export pump deficiency.
Poster FRI-131: Psychometric evaluation of the adult itch reported outcome tool, a worst-itch numeric rating scale in adults with cholestatic liver disease.
Poster FRI-296: Differential expression of bile acid subspecies with maralixibat treatment in pruritus responders.
